Novartis Venture Fund
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Relation
11 Dec 2025
Relation secures £40m in strategic backing from Novartis to advance drug discovery for atopic diseases
Relation develops an AI-driven drug discovery platform that combines human data and experimental systems to identify and validate new therapeutic targets for immune-related diseases.
NRG Therapeutics
8 Sept 2025
NRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapies
NRG Therapeutics develops oral small-molecule drugs targeting mitochondrial dysfunction, aiming to slow or halt neurodegenerative diseases such as ALS and Parkinson’s through disease-modifying treatments.
Novartis Venture Fund
- 2(12 months)
- nvfund.com
- Update Information
More venture news
- 20 May 2026
eSIM GoeSIM Go lands strategic investment from TNS Global to scale its travel eSIM and mobile network infrastructure
StrategicTelecoms - 15 May 2026
MultiverseMultiverse secures £52m led by Schroders Capital for AI and data upskilling platform for enterprise workforces
StrategicHR - 11 Feb 2026
AMPLYAMPLY Discovery secures strategic investment from Keeps Biomed for its AI-led oncology drug discovery solution
StrategicLife Sciences
